We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Simon Saxby Joins Board at Selcia

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Simon Saxby is currently Vice-President Biologics of RecipharmCobra Biologics, a Swedish contract development and manufacturing company and has worldwide responsibility for the manufacturing of biologics.   Simon has over 25 years experience in the biotechnology industry, including several CEO positions, most recently at Cobra Biomanufacturing plc and Alpha Biologics.  He brings a blend of technical, business, sales and marketing skills and senior management, fund-raising and M&A experience.

Commenting on the appointment, Managing Director of Selcia, Dr Hans Fliri said: “I am delighted to welcome Simon to the management team.  Simon brings with him his considerable international experience, technical knowledge and commercial expertise.  We look forward to Simon helping us accelerate our UK and international market development plans”.